President Donald Trump’s allies are resurfacing a proposal from the first Trump administration that would dramatically cut ...

SaveHealth reports on the third-party companies that work to negotiate discounts with pharmacies and pharmacy benefit ...

Bipartisan legislation was reintroduced by Reps. Joe Courtney (D-CT) and Erin Houchin (R-IN), shining light on the prescription drug pricing system to provide fair deals to patients. The bill (320-71) ...

Fosamax further defines the obligation of drug manufacturers to present clear, unambiguous, and accurate information to the ...

Rogaine was approved by the Food and Drug Administration in 1988, the first drug to win the agency’s endorsement for male ...

If enacted, the legislation would create an independent, nonpartisan board of medical and health experts tasked with ...

A 20% tariff on Chinese imports could drive up the cost of generic prescription drugs, which could impact pharmacies and ...

The Office of Insurance Regulation is demanding the unusual trove of data from pharmacy benefit managers — health care ...

If left unchecked, the power of PBMs and their complex relationships within the American healthcare system could lead to higher drug costs and diminished returns.

Governor Kathy Hochul has launched DFS Connect, a new digital platform from the New York State Department of Financial ...

The bill, which encompasses the recommendations of a task force, would regulate pharmacy benefit managers and increase price ...

Health analysts and generic drug manufacturers said the 20% levy from two rounds of tariffs on goods imported from China − a major supplier of medical equipment and prescription drugs for the ...